1019767-65-7

Basic information

• Product Name: 3-[4-(benzyloxy)pyridin-3-yl]-3-hydroxy-1-pentyl-1,3-dihydro-2H-indol-2-one
• Synonyms: 3-[4-(benzyloxy)pyridin-3-yl]-3-hydroxy-1-pentyl-1,3-dihydro-2H-indol-2-one
• CAS NO: 1019767-65-7
• Molecular Weight: 402.493
• Mol File: 1019767-65-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[4-(benzyloxy)pyridin-3-yl]-3-hydroxy-1-pentyl-1,3-dihydro-2H-indol-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[4-(benzyloxy)pyridin-3-yl]-3-hydroxy-1-pentyl-1,3-dihydro-2H-indol-2-one(1019767-65-7)
• EPA Substance Registry System: 3-[4-(benzyloxy)pyridin-3-yl]-3-hydroxy-1-pentyl-1,3-dihydro-2H-indol-2-one(1019767-65-7)

Safety Data

• Hazardous Substances Data: 1019767-65-7(Hazardous Substances Data)

Upstream product

• 4290-90-8 1-pentylisatin 
• 1019767-63-5 4-(benzyloxy)-3-bromopyridine 

Downstream Products

• 1019767-66-8 3-[4-(benzyloxy)pyridin-3-yl]-1-pentyl-1,3-dihydro-2H-indol-2-one 

Relevant articles and documents

SPIRO (FURO [3, 2-C] PYRIDINE-3-3 ' -INDOL) -2' (1'H)-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF SODIUM-CHANNEL MEDIATED DISEASES, SUCH AS PAIN

This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein j, k, m, Q, X,, R1, R2a, R2b, R2c, R2d and R3 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, N-oxide, solvate or prodrug thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.